The $59 Billion
“New You” Revolution

Look at the picture to the right.

Imagine a simple injection that completely rejuvenates someone’s cartilage in their knees, shoulders, back, and hips… and gives them the heart function of someone in their 30s.

It would be like the movie “Seventeen Again.” Overnight, they’d have the mobility, flexibility, and energy of someone decades younger.

These emerging technologies known as “Regenerative Medicine,” or the “New You” Revolution, could do just that — and sooner rather than later.

It’s a massive $59 billion market, creating a once-in-a-lifetime opportunity for early investors in the right companies, who could see shares soar up to 10X higher. 

This is what happened in the past when revolutionary medical technologies first appeared.

For example, when Pfizer began selling penicillin in the 1940s… it launched what became known as the “antibiotic revolution” …

A revolution in medicine that would go on to save the lives of hundreds of millions.

Pfizer went public in 1942… doubling its market cap the same day.

And then proceeded to grow its market cap by over one million percent by 1958.

As impressive as that is, consider this… the stock split eight times during that span! 

Now we’re on the brink of another major revolution in medicine, the market for which is currently estimated at $59 billion.

And just like Pfizer in 1942, I believe there’s one small, unknown company at the heart of the “New You” Revolution.

It’s positioned to dominate this rapidly exploding market — and we believe it could make early bird investors up to 10 times their money.

And get this…

It’s NOT on the Dow.

It’s NOT on the S&P 500.

It’s NOT on some remote offshore foreign exchange.

Now, I’ll reveal more about this company — and the “New You” Revolution — in just a moment.

But first, let me tell you how I know about it.

My name is George Gilder. I’ve successfully predicted many world-changing tech revolutions years in advance in my bestselling books, such as Wealth and Poverty, Life after Television, Knowledge and Power, and many others.

I also make frequent appearances presenting my analysis of breaking scientific trends. I’ve made countless appearances in The Wall Street Journal, The Economist, and the Harvard Business Review, just to name a few.

But my real work for the past four decades has been as a futurist and technology investor. Forbes Magazine even claimed…

I appreciate that, but…

There’s a reason why most tech experts don’t get the word out for investors until it’s too late.

Many of the key leaders in technology seldom write. And if they do write, it’s in complex technical language.

So I do as much as I can to get the word out.

For example, in 1985 I personally briefed Ronald Reagan.  I told him, “Mr. President, what I hold in my hand right now will change the world forever.”

And dropped a microchip into his outstretched palm.

That very same year, Intel went from losing $1.73 billion…

… To doubling its stock price two years later…

And then to dominating the microchip market, gaining an amazing 8,875% through 2023, as seen below:

A $10,000 investment at that time could have transformed into $887,500 today. I also predicted the Smartphone Revolution thirteen years before Apple released the iPhone…

And by the start of 2024 … 6.95 billion cell phones were in use. (Some people have two).

Apple stock did a moon shot. 

A $10,000 investment when the iPhone was released in 2007 — could have soared 3,833% by the start of the year.

Who wouldn’t be thrilled today, with an extra $383,300 in their retirement? I also predicted the fall of network television (ABC, NBC, CBS) a full 10 years before Netflix came on the scene in 2002.

And a $10,000 investment, when Netflix first unleashed its streaming service in 2007…

Would have become $2,210,400 — for a 22,104% gain by this year, as seen below…

However, don’t think I’m just tooting my own horn.

Steve Forbes called me…

Bill Gates declared I am….

And the founder of CNET said this about me:

Now I’m not saying all of this to brag.

In fact, I’m usually the first to caution investors that past performance is not proof of future results.

But the reason I am writing this today is because the New You revolution” reminds me very much of the previous disruptive technologies I predicted:

• The microchip…
• Smartphones…
• Video streaming…

And these are only a few technologies I’ve predicted that changed the global economy in fundamental ways.

But here’s the thing…

When a technological revolution occurs, investors usually don’t have a lot of choices. 

Often, there are just one or two companies who bring the technology to market.

This was the case when iPhones came on the scene. An investor who believed in the potential of the touchscreen smartphone had almost no choice but to invest in Apple.

The same was true with streaming video. An investor who saw streaming video’s potential to disrupt the TV and movie markets, as I did, had to invest in Netflix.

Well, I believe the same dynamic is true with New You medicine.

There are many privately funded startups involved in this major change in healthcare… but only a tiny handful of publicly traded companies.

I’m currently researching three regenerative medicine companies that could revolutionize health and healing.

But according to my research, only one is poised to lead the pack at this time.

And the company I’m talking about has the potential to see its shares grow up to 10X higher than today’s price.

By focusing so intently on these opportunities, I don’t really care about what’s going on in the market as a whole.

Instead, I do in-depth research to ask one question:

“Which company is disrupting the status quo the most?

And when I discover a company that’s really shaking up the establishment…

I research that company to see if it has staying power.

And to see if it’s going to make a giant impact in the future.

And THAT is what I invest in.

And then urge my followers to join me.

This is called “early stage investing.”

That’s why the $50 million man, James Altucher, claims:

Over the years, my team and I have identified companies that went on to make their early investors massive gains because we carefully dig through mountains of financial data and statistics.

And while few people have the time or patience to be this thorough…

This is my life. And I love it!

It’s my mission to identify future trends and successful investments that are changing the world.

And now I’m here to show why what I’m calling the “New You” revolution could change the lives of BILLIONS of people… and may utterly transform how medicine is practiced all over the world.

This is HUGE. I see this turning present-day medicine on its head, like other revolutionary technologies have, such as:

• Antibiotics
• X-Rays
• Anesthesia

Yet even today’s miracle technologies look primitive in comparison to the New You revolution.

Take cancer, for example.  Conventional medicine often uses powerful chemotherapy drugs to shrink cancer tumors…

But these drugs can carpet-bomb the patient’s immune system with toxic chemicals…

In contrast, “New You” technologies seek to repair or replace what’s damaged in the body, whether it’s diseased cells or entire organs…

Without relying on invasive surgery, potentially toxic drugs, radiation or other invasive procedures… and might eventually eliminate the need for donor lists

And in many cases, it dramatically reduces long recovery times.

This is a fundamental reason why the New You revolution is gaining so much attention.

It has the potential to address diseases, ailments, injuries and disabilities once thought untreatable.

And as the New You revolution picks up steam…

It presents investors with what could be one of the biggest opportunities of a lifetime…

First, the number of people needing regenerative medicine treatments today is massive.

With the treatments available today and in development, doctors could potentially help, in the United States alone:

• 32.5 million arthritis patients
• 13 million heart disease patients
• 6.7 million Alzheimer’s patients
• 2 million rotator cuff patients
• 1.9 million cancer patients
• 1.24 million knee and hip replacement patients
• 879,242 Lymphoma patients and
• 437,337 Leukemia patients

And that’s just a small sample of people New You regenerative medicine may help.

Government regulators estimate that…

One in every three Americans?

That’s 109.8 million people!

That many patients can fill each U.S. hospital bed today 119 times.

And as I’m about to reveal, one company is uniquely positioned to provide New You solutions to this huge group of patients.

As it also washes away the obsolete technologies of the past…

Very soon, many of the treatments common today may be dismissed as virtual superstitions… like the bloodletting practiced by doctors for 2,000 years, until the end of the 19th century.

In fact, I believe this company that has the potential to become the Pfizer of the New You revolution…

… a pioneer in an entirely new way of practicing medicine…

… and as a result see the price of its shares explode — I believe up to 10x higher.

Next, there’s a second, deeper reason why regenerative medicine is the future … what I call…

“Un-Surgery”

“Un-Surgery” is the surgery that never has to happen.

The real potential of New You regenerative medicine is that it could make many surgeries completely unnecessary.

For example, scientists are already testing some New You therapies as a replacement for surgery when it comes to the world’s biggest killer: heart attacks.

• Johns Hopkins is already using regenerative medicine to “repair damaged heart muscle in patients with chronic heart failure.”

• Cedars Sinai treats individually selected patients “concerned with heart disease progression” with advanced New You regenerative medicine techniques.

• And the Mayo Clinic is currently developing not one but five new regenerative technologies that focus on cardiac failure.

The ultimate goal of all these efforts is total cardiac regeneration… the renewal of damaged heart tissues for a new heart.

Take the example of Dave Randle, a 48-year-old truck driver for big bands such as Bruce Springsteen and U2.

After suffering a near-fatal heart attack, Randle was given the news that he had only 12 months to live. 

He was too weak for a heart transplant.  The only thing he could do was go home and wait to die.

Randle suffered from something called “Ischemic cardiomyopathy”:

Damage to his heart muscle caused by a narrowing of the arteries. 

His doctor told him to put a DNR (“Do Not Resuscitate”) note on his medical records. And referred him to a local hospice for end-of-life care.

Yet Randle decided he wasn’t ready to die. 

He heard about an experimental New You treatment being tested by a heart foundation.

He decided he didn’t have anything to lose.

Randle traveled to London, England, for a clinical trial.  Over five days, he received injections of a special serum made from his own bone marrow to stimulate the regrowth of his failing heart cells.

The results were nothing short of miraculous.

Within days, his heart function improved. 

Within weeks, Randle recovered much of his strength.

And doctors told him he was on the road to total recovery. 

Today Randle spends a lot of his time getting the word out about the New You treatment that saved him from certain death.

“Don’t just accept your death sentence,” Randle tells audiences that come to hear his story. “There are options out there.”

There are indeed.

While cardiac breakthroughs are rare in conventional medicine… they are becoming increasingly common in the new world of the New You revolution.

And as I keep saying, one small, unknown company is in the thick of things, with the know-how to implement these advanced cardiac treatments…

And license its cardiac technology to other biotech companies.

Because of cardiac regeneration technology alone, I’m convinced the financial potential here is massive.

That’s why savvy investors are flocking to this tiny, unknown company.

Up 75.9% in the first quarter of this year alone.

It’s now selling for My research indicates this company has the power to make early investors many times their money… like other breakthrough biotech stocks that made similar staggering gains…

• 11,000% on Medivation (MDVN); for a promising treatment for Alzheimer’s
• 5,000% from Questor (QCOR) for its advanced multiple sclerosis treatments
• 3,900% from Illumina (ILMN) for its genetic sequencing technology

And as impressive as gains like these are…

There is yet another reason why this one company could present investors with one of the biggest investment opportunities ever.

It’s because …

New You Medicine Could Go Global Fast!

The New You revolution is not limited to the U.S.

It has grabbed the attention of the entire world.

New You scientists developing regenerative medicine technologies have won two Nobel Prizes in the last decade.

In fact, the company I’m talking about has a footprint in all of these countries seen below:

Strategically, this tiny company is in an enviable position… because it’s marketing crucial technologies desperately needed worldwide — and working with centers in North America, Europe, the Middle East, and Asia….

And many partner companies around the world.

This means the more biotech companies in business, the more this company stands a chance to profit from many of them.

Simple, right?

And after exhaustive research, it’s plain to me that this company can…

• Trigger the “New You” Revolution worldwide the way Pfizer triggered the antibiotic revolution in the 1940s and ‘50s…
• Dominate the “New You” medicine market with unique technologies
• Give early investors the opportunity to make a killing on their investment… the way other investors make huge profits investing in tech stocks like Medivation, Questor, and Illumina.

But if this world-changing medical breakthrough is so powerful, some investors may wonder …

“Why Haven’t I Ever Heard of the New You Revolution?”

The answer is simple: it’s the same reason why many investors didn’t hear about penicillin in the 1930s.

They would have had to wade through stacks of boring scientific journals each month…

Or become intimately familiar with small, fast-growing companies few people even knew existed.

Or meet with CEOs in person and ask them to make their case to you… like I do.

And I also have a first-rate team of researchers and analysts.

We’re constantly unearthing new companies long before they hit Wall Street’s radar.

And like I said, you won’t find this company in the Dow, or the S&P 500.

So now, let’s take a peek inside of….

How the $59 Billion “New You” Revolution is Sweeping Away Conventional Medicine

The New You revolution is about to tear through the landscape of the medical bureaucracy like a cyclone.

I’ve already given you a couple of examples of how powerful New You is…

Here’s another one:

The leading cause of disability in America is arthritis.

And the single, LARGEST nonprofit dedicated to the prevention, control, and cure of arthritis…

… is shouting this from the rooftops:

Again, New You medicine “… show(s) promise for osteoarthritis …. diabetes … cancer … Parkinson’s disease…”

Instead of traditional medicine’s “cut, chemo, and drug” treatments… New You medicine takes a completely new approach.

For example, by just injecting a specific gene into a patient’s own cells…

… Using a harmless “virus” as a carrier for the gene-modified cells…

It can reprogram cells to treat diseases in just a few steps, as shown in the image below. 

These New You technologies — treating patients with their own cells — has the potential to change the course of medical history.

That’s why the time to invest is now… before the company I’m talking about is discovered by Wall Street and sees its share explode.

When people discover the potential these technologies have, I expect billions of dollars to flood into this one tiny company, potentially driving share prices up to 10X higher.

Could this company end up a $400 stock, like Vertex Pharmaceuticals… or other big biotechs today.

That’s my opinion. And because I’m convinced this is the dawn of a new age for humanity.

Let me address another question many people have…

Why Can’t Doctors Give ‘New You’ Medicines Now?

The answer is: they can!

Many are available today. And many more are coming very soon.

However, there is one big, expensive obstacle to the mass marketing of regenerative medicine technologies — which has a simple, cost-effective solution. And the company I’m talking about has the answer. 

Let me explain…

Much of New You medicine relies on working at the cell-level of the body.

For example, they are developing serums for the regeneration of cartilage to treat knees, hips and shoulders crippled by arthritis.

But many clinics extract these cells, and ship them to a distant location.

However, human cells, outside the body, are very delicate.

It’s possible to rupture a cell’s wall simply by breathing on it.

They must be handled with extreme care. And they don’t live long outside the body.

So handling and shipping genes is even more expensive and even more complicated.

Furthermore, when working with “living” genes, everything must be as sterile as possible…

But living genes themselves can’t be sterilized (the high temperatures of a sterilizer would kill them) …

So the whole process must be conducted in a clean room, costing millions of dollars to create and maintain.

Even worse, inserting genes into a cell is like an extreme form of microsurgery: Hard to do and something that can easily go wrong.

Bottom Line:

While many New You treatments are already here… at the moment each local medical center is forced to engineer its own applications for using them. 

That means these facilities are forced to reinvent the wheel.

In other words, everyone’s doing their own thing. There is little or no standardization. Or mass production.

These two issues alone make the price of New You medicines astronomical.

Yet the bigger the problem, the bigger the potential for solutions…

And often the bigger the returns on investment.

Thankfully, the solution I’m about to reveal aims to solve each problem above…

And dramatically accelerates the time-to-market for many new regenerative New You medicine treatments…

Mostly by creating standardized procedures throughout medical facilities around the globe.

Standardization could make many complex medical treatments as simple as picking out a treatment “recipe” … and creating it with uniform manufacturing techniques.

Which makes new therapies available much faster. And far less expensive.

Let me unveil…

The Simple New You Solution = Potential BILLIONS in Profits

The company I’ve been talking about has created a way to standardize “New You” medical technologies and make them affordable on a global scale.

In other words, this company is about to do to the “New You” revolution what Pfizer did for antibiotics… and what Henry Ford did for the automobile…

Here’s what I mean:

Back in the early 1900’s, cars were custom assembled in tiny locations, scattered across America…

Much like New You medical labs today.

Many of the car’s parts were painstakingly made by hand… or with the help of custom-made machines.

In other words, there was little or no standardization.

So each part may have been a little different from the last one… and may not have fit without hours of special adjustments.

As a result, the number of cars produced in the early days was limited by how fast the workers could manually complete each task.

Much like other New You medical labs and clinics today.

The custom-made automobiles produced were a luxury item that only the super-wealthy could afford.

Much like New You medical manufacturing labs today.

Henry Ford changed all that.

He developed the assembly line, gathered together the best technologies then in use, standardized them, and then proceeded to mass produce automobiles on a massive scale.

That was Ford’s biggest dream, to “democratize” the automobile.  To make cars available to all.

My goal is similar.  I want to help everyday investors take advantage of the potential for mass producing New You medical technologies.

To make them available to you instead of just to super-rich billionaires like Jeff Bezos, Peter Thiel, and Elon Musk.

I want to help the average Joe get…

Up to 10X Returns from Standardizing New You Medicine

This opportunity exists for the same reason Henry Ford could make his dream come true.

There’s almost no standardization with New You medicine.

No shared platform for creating treatments.

No cookie-cutter methods like Big Pharma enjoys when they churn out pills by the billions.

Instead, in New You medicine, nearly everybody has their own production set-up:

• Their own hardware…
• Their own software…
• Their own processes, analytics, and quality control…

It’s like each New You practitioner constantly reinvents their own version of the wheel.

Credit: Stable Diffusion

It’s slow. And painful. And expensive.

Yet the company I’ve been talking about is speeding things up and slashing expenses…

…By standardizing New You treatments in labs around the globe…

And then selling these standardized treatments, facilities, and lab procedures…

For hospitals, medical centers and research universities around the world.

What do I think will happen as a result of this visionary company’s commitment to democratizing New You medicine?

The same thing that happened when Ford standardized automobile manufacturing.

Ford changed the world by helping put it on wheels.

And this visionary company could change the world by helping cure countless ailments, illnesses, and physical accidents… not to mention the problems associated with old age.

The company could help eliminate much of the suffering in the world with its standardized treatments and production facilities.

So make no mistake: This is a multi-billion-dollar industry… and this company is at the forefront, helping make it all possible.

This company is to the New You medicine industry what Microsoft was to Personal Computers… and Apple was to smartphones.

In other words:  a leading pioneer that makes an entire industry possible.

And that’s not just my opinion.

Here are a few of the big-money companies and funds that are heavily invested in this company’s future:

There are plenty more…

As you can see, some of the smartest investors in the world hold shares of this company.

I’m simply urging other smart investors to follow their lead… and to be part of what could be the biggest medical revolution since the discovery of antibiotics.

Allow me to present…

One New You Company to Rule Them All:

There may never be another opportunity like this in our lifetimes. Why?    

This New You company has a HUGE jump on technology over its competitors.

For starters, these New You labs are built… and then shipped almost as easily as a container on a tractor-trailer truck.

They are like prefabricated buildings.

Relatively easy to build from standardized models… and available with additional options…  and delivered, then set up at a hospital or clinic.

That means cookie-cutter lab models that can be mass produced…

Made from a standard blueprint… which is like a design “schematic” for standardizing New You labs…

Stocking them with standardized equipment…

And even supplying standardized “protocols” for treatments these labs will produce.

In other words, this means massive savings are possible from the standardization of treatment labs, methods and therapies… as well as instruments, procedures or software.

And here’s the best news of all: you can find out all about New You medicine…

And the company making it all possible in my brand-new investment report:

“The New You Revolution: Up to 10X Profits in Regenerative Medicine” …

There’s serious money on the line here…

By having a New You lab onsite… hospitals, clinics, and research colleges now have many crucial advantages over other hospitals, clinics, and research colleges…

They include…

• Onsite production of advanced therapies for faster implementation.
• Lower costs of production (through standardization)
• Increased quality control (through standardization)
• Lower transportation costs, risks, and errors (because the lab is on-site)
• Streamline staffing needs (dedicated scientific professionals)
• Onsite clean room alternatives that deliver results at much lower costs

• The ability to “mass-produce” treatments for wider distribution
• And many other benefits

What’s more, helping this company could help end suffering for countless people worldwide.

By creating access to tomorrow’s medicine for inexpensive, widespread distribution.

All of this adds up to giving investors the chance to cash in on what may be one of the biggest investment opportunities of their lives.

Even better, this company has never stopped innovating miracle cures to sell to other medical professionals.

And it holds no fewer than 17 patents — and continues to develop unique, high-value treatments.

Here are some of their milestones:

By the way… that’s only a partial list, since 2020.

Check out the diseases being targeted in their research and development pipeline today:

Is there any ailment this world-class company hasn’t set out to eliminate?

Even if it only succeeds on a couple of fronts, this company is still set up to change people’s lives.

And I give away the details investors need to get into it, as a bonus, in my special report: The “New You” Revolution:  Up to 10X Profits in Regenerative Medicine.

The stakes are high. Millions of people around the globe need these advanced regenerative medicine treatments.

For some patients, it’s literally a matter of life and death.

And this company just might bring about the greatest medical breakthrough in over a century.

Finally, I want to simplify how the company’s business model works:

Quality skyrockets. Costs plunge. People with no hope get help.

My research suggests, as this company’s new technologies catch on, its shares could skyrocket — 10X or more.

And it’s not just an opportunity for investors in this one company…

The entire sector could benefit…

I foresee huge numbers of hospitals, universities, clinics, and biotech companies lining up at the company’s door to buy its labs.

This company boasts the lower-cost advantage of a ready-to-go, onsite lab with standardized regenerative medicine treatment protocols and practices, with a virtually untapped market.

Their ready-to-go, standardization procedures alone make it nearly impossible for other companies to jump in the market.  As Warren Buffett would say, the company has created a wide economic “moat” against competitors.

That means it would be incredibly difficult for another company to start from scratch for three reasons:

• Years of development went into the development of its mass-produced, standardized regenerative medicine lab… meaning new companies would have to start from scratch and play catch-up
• Its 17 unique patents, and a pipeline of over 30 licensed gene and cell therapies
• Multiple standardized treatments and procedures, the result of years of intellectual property development

So I believe this company is a mountain of profits, ready to be mined by savvy investors.

However, one caveat: by the time this company becomes a public name like Apple or Netflix… it may be too late for most investors to get in at the bottom.

That’s why I think smart investors will get in now… when the company’s shares are super-cheap.

Which is one reason my research shows a red-hot 10X profit potential…

Because, for now, this company is at a growth stage where it can be purchased on a special exchange: 

The OTC (over the counter) market.

Which is an exchange for smaller companies…

Just ready to be plucked off the vine by savvy investors at bargain-basement prices. 

Now, the New You company can be bought and sold through many of the usual brokerages… Fidelity, Vanguard, Schwab, E*TRADE, Merril Lynch, Trade Station, etc.

And I love OTC stocks, because when I find one with enormous potential, and a lower share price… 

And the New You company is, for now, one of those…

It means the potential is there to multiply even a small investment many times over.

And, the way I see it…

Investing in this New You revolution company is like having a front row seat to history in the making…

And it all starts with a premium bonus copy of my special report:

The “New You” Revolution:  Up to 10X Profits in Regenerative Medicine.

Inside there’s the name of this company, its ticker symbol, and why now is a great time for investors to take a position in it… 

Like I said earlier… while it still has a bargain-basement price.

But this is only the beginning.

I also want to give out far more than just information about this one company I project to skyrocket to incredible wealth… and more than just the secrets contained in the report I mentioned earlier…

In fact, I have an entire portfolio of some of the biggest technology disruptors coming in the near future.

So now I’d like to reveal…

The Secret to Spotting Moonshot Companies Early

Successful early-stage investing is like following the trajectory of a rocket from its launch to its deep-space destination.

Stocks and rockets go through the same six stages of flight:

THIS is the secret principle my team’s stock-growth research hinges on:

These simple-to-understand, but incredibly thorough six stages define where a new tech company is in its stock price growth cycle…

And what my team sees as its next logical move.

Six Moonshot Stages:

• 1. LIFTOFF

Liftoff companies are emerging technology companies that are at a very early stage of commercialization.

They have disruptive products with tremendous potential to generate outsized investment returns.

This is the stage where the New You company is today… inexpensive and not yet discovered by the general public.

Not only does our research show it has the potential for enormous returns in its early liftoff…

And we’re super-excited because our research says this stock could soar at warp speed through the next five stages for continued monster-sized gains in the years ahead.

• 2. TEST FLIGHT

Test-Flight companies are breakthrough technology stocks we have a strong conviction for.  These are companies we don’t want to miss.

But our requirements are strict. We feel their biggest gains are yet to come.

So we keep stringent investing rules in place.

• 3. ESCAPE VELOCITY

Escape Velocity companies are gaining traction in their markets through:

• Growing product/service adoption
• Having a strong edge over the competition
• A powerful management team
• Experiencing fast-paced growth

• 4. ORBIT

When a company reaches orbit, it is maturing, stabilizing, and staying in its lane.

It’s making incremental improvements to its projects, perhaps positioning itself for a new trajectory… like gaining widespread name recognition as a “new technology” which we believe will lead to a long-term growth trajectory.

• 5. COURSE CORRECTION

HUGE potential!!

Also known as “fallen angels.”

These are proven technology companies that have reached orbit but have hit a problem. Maybe they’ve had a scandal. Or they’re in need of a turnaround… like management changes (e.g., appointment of a new CEO).

A successful Course Correction can dramatically boost a company’s valuation.

• 6. DEEP SPACE

A Deep Space company is growing fast via increasing market demand, acquisitions, strategic partnerships, and other value creating initiatives.

Such companies are executing at a high level in the marketplace and are deserving of the highest position weight in our rating system.

Here’s my point:

This six-stage system is the long-term secret my team has held close to the vest that lets us evaluate a stock in terms of which stage it’s in…

And its profit potential:

And help determine if it’s a great investment now.

That’s the beauty and simplicity of our system.

What’s more, we have a separate portfolio of individual stocks for EACH stage of development.

And I want to share every one of our potential blockbuster companies in each of these six portfolios as well.

And all I ask in return is to…

Accept a 30-Day Preview of My Elite Advisory Service, Gilder’s Moonshots

Gilder’s Moonshots is an advisory service unlike any other I’ve seen.  It’s specifically designed to take advantage of the sky-high profit potential in brand new tech companies…

… The micro-caps, small-caps, and even pre-IPO opportunities that seem to be everywhere today.

But here’s the thing: there are so many ideas for new tech out there it’s hard to tell the bad from the good.

But not for the Moonshots team… not with our secret six-portfolio system.

Between the members of our team, we have more than 100 years’ experience in ferreting out some of, in our carefully chosen opinion, the best money-making new technology opportunities over the last five decades…

Each of Gilder’s Moonshots six portfolios contains our ongoing research of future trends, as I’ve called them for decades…

And my specific recommendations for making money from them.

And today… you can get instant access to it all… along with my new special report, simply by taking me up on a special 30-day, 100% money-back preview offer.

We’re talking about a full month’s unlimited access to Glider’s Moonshots.

Once you agree to this test drive, I’ll send all the details on the New You tech company I strongly believe could see its shares blast-off up to 10-times higher in the near future…

It’s all found in this special report that I’m giving you as a gift for accepting a 30-day guaranteed preview:

The “New You” Revolution: Up to 10X Profits in Regenerative Medicine.

My research suggests this company’s stock is not only vastly underpriced…

It’s ready to break out in the very near future.

My team and I believe this company could easily explode into one of the most profitable tech stocks on the market.

This OTC New You company could quickly become one of the most profitable investments I’ve ever seen.

In fact, this opportunity is so urgent that I’m going out on a limb… and giving out its name to investors for simply agreeing to a 30-day preview of Gilder’s Moonshots.

Now, Gilder’s Moonshots is a high-end, fast-paced service.

And we will be with you every week, guiding your portfolio with a combined 100 years of experience.

Bottom Line: You get access to all the above… backed by my track record, research skills, and leadership experience, from my team which has nearly 100-years combined experience giving investment advice.

It’s my mission to give investors access to everything I have to help them make money from the latest technology innovations. Which means I’ll do all the heavy lifting for them.

But even so…

Gilder’s Moonshots May Be Out of Some People’s Comfort Zone

The truth is, early-stage tech investing is not for everyone.

Some people prefer the predictable 5% returns (and less risk) that come with mutual funds, dividend stocks, CDs or annuities.

However…

After seeing the potential 4- and 5-digit profits my recommendations could have generated…

After seeing how we’ve forecasted world-disrupting technologies over a decade in advance…

After seeing how mega-companies — like Intel, Apple, and Netflix — built massive, world-changing technologies from trends we predicted before they happened…

After seeing what I believe to be a great way to possibly multiply an early investment 10-times over…

I believe it’s a no-brainer to accept a 30-day preview of our service.

I’ve made it super-simple.

There’s nothing complicated to learn.

When I have a recommendation, I simply email members telling them what to do… plain-English instructions on what to buy, when to buy, and when to take profits.

Simply follow our recommendations. That’s all it takes.

So how much does it cost to become a member of Gilder’s Moonshots today?

Keep in mind that Gilder’s Moonshots isn’t just an investment group — think of it more like an exclusive “hedge fund-type” research service.

That’s because we’re focused on market niche — microcaps with disruptive technologies — and know it well.

We’ve become experts in these technological and even medical revolutions because much of the development flows from microchips…

And what they make possible, including Artificial Intelligence.

Now, some Wall Street boutique firms charge tens of thousands of dollars for this kind of research.

While hedge fund managers rake even more, typically charging a 2% annual management fee—AND 20% of the profits for their research…

And that’s what we should probably charge for Gilder’s Moonshots, given the caliber of analysts helping me run it.

But Gilder’s Moonshots won’t cost tens of thousands of dollars…

Or even $10,000.

One year of Moonshots regularly retails at $1,995.

And I know it’s worth every penny and more.

But given how fast these tiny, early-stage microcaps can shoot up…

I want to encourage investors to take action today…

So here’s what I decided to do: I am going to offer this opportunity to try out Gilder’s Moonshots for the remarkably low price of just $995 for one year.

That’s 50% off the regular membership fee.

If you’re not ready to commit to a year, you can join today for $275 each quarter.

But time is of the essence to get in at this good price. It’s only being offered today to the first 50 people who sign up.

After that, new members may have to pay the full annual price of $1,995. And of course, we’re also offering a 100% satisfaction, money back guarantee in the first 30 days.

If—for any reason—or no reason at all —Gilder’s Moonshots doesn’t meet your every expectation, simply call our VIP customer service team at 866-223-4966 and request a refund of your membership fee.

Or send them an email, and we will RUSH back every penny of the subscription fee.

NO QUESTIONS ASKED.

To get started, simply click the button below.

It will take you to a secure page where you can review everything without making any commitments.

However, please know this:

I only want investors who are ready to act now on this breaking New You medical technology…

Because I can’t see it being at its present price for long.

I want members who will jump at the chance to invest in what could be the next Nvidia, Apple, or Netflix — especially since it may be still undervalued…

The truth is, I’ve made tons of money.

The only thing left for me, at this stage in my life, is to pass on my legacy to serious tech investors.

And I only want to work with investors who want to benefit from this.

So if Gilder’s Moonshots isn’t a good fit, there’s no hard feelings.

Just step aside and let someone in who wants this investment research.

But for anybody who’s stayed with me this far…

…I believe they’re the kind of investor that will take my recommendations seriously.

So I’m extending a welcoming hand.

Click the button below now, and let’s get started:

So go ahead… hop-on for the 30-day preview. Just click the button below to get started.

Yours for higher profits

George Gilder
Editor & Investment Director, Gilder’s Moonshots